NCT00353262View on ClinicalTrials.gov

A Study of Xeloda (Capecitabine) in Combination With Oxaliplatin in Patients With Metastatic Colorectal Cancer.

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

September 30, 2006

Study Completion Date

April 30, 2008

Conditions
Colorectal Cancer
Interventions
DRUG

Avastin

7.5mg/kg iv (cycle 3 only)

DRUG

Oxaliplatin

130mg/m2 iv (cycles 1, 2 and 3)

DRUG

capecitabine [Xeloda]

1000mg/m2 po bid (cycles 1, 2 and 3)

Trial Locations (3)

L8V 5C2

Hamilton

K1H 8L6

Ottawa

M5G 2M9

Toronto

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT00353262 - A Study of Xeloda (Capecitabine) in Combination With Oxaliplatin in Patients With Metastatic Colorectal Cancer. | Biotech Hunter | Biotech Hunter